proxy_investor
@proxy_investorJuly 14th, 2022 23:38 “Syngene signs 10-year biologics manufacturing
agreement with leading animal health company, Zoetis”.
Partnership… https://t.co/GUnMAHWEK3
proxy_investor@proxy_investor July 14th, 2022 23:38 “Syngene signs 10-year biologics manufacturing
agreement with leading animal health company, Zoetis”.
Partnership… https://t.co/GUnMAHWEK3
proxy_investor
@proxy_investorFebruary 28th, 2022 21:31 Viatris will contribute to Biocon Biologics its biosimilars portfolio, related commercial and operational capabilit… https://t.co/fPEIQu3vRe
proxy_investor@proxy_investor February 28th, 2022 21:31 Viatris will contribute to Biocon Biologics its biosimilars portfolio, related commercial and operational capabilit… https://t.co/fPEIQu3vRe
proxy_investor
@proxy_investorFebruary 28th, 2022 04:45 Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Immediately A… https://t.co/L90L7PhvGy
proxy_investor@proxy_investor February 28th, 2022 04:45 Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Immediately A… https://t.co/L90L7PhvGy
proxy_investor
@proxy_investorJune 30th, 2021 23:25 Sequent Scientific - Q4FY21 and FY21 -
Moo'in, chuckling, oink'in, baa'in the right way
Dividend of Rs. 0.50… https://t.co/bSt6ePsESs
proxy_investor@proxy_investor June 30th, 2021 23:25 Sequent Scientific - Q4FY21 and FY21 -
Moo'in, chuckling, oink'in, baa'in the right way
Dividend of Rs. 0.50… https://t.co/bSt6ePsESs
proxy_investor@proxy_investor May 30th, 2021 20:07 RT @Kiran24Rajput:
proxy_investor
@proxy_investorMay 19th, 2021 18:33 Alkyl Amines Chemicals - The #bitcoin of the Indian stock market, but definitely less risky and more valuable to HO… https://t.co/X0NpaE2pqp
proxy_investor@proxy_investor May 19th, 2021 18:33 Alkyl Amines Chemicals - The #bitcoin of the Indian stock market, but definitely less risky and more valuable to HO… https://t.co/X0NpaE2pqp
proxy_investor
@proxy_investorMarch 26th, 2021 02:20 RT @SyngeneIntl: Syngene is a full-service #Biologics #CDMO offering end2end development & manufacturing from clinical to commercial supply…
proxy_investor@proxy_investor March 26th, 2021 02:20 RT @SyngeneIntl: Syngene is a full-service #Biologics #CDMO offering end2end development & manufacturing from clinical to commercial supply…